Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 2/20 | 0.48 |
| ▸ | CYP11B2 | P19099 | 2/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.43 |
| ▸ | CYP2A6 | P11509 | 2/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | ATM | Q13315 | 2/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | KIF11 | P52732 | 1/20 | 0.40 |
| ▸ | TNKS | O95271 | 1/20 | 0.40 |
| ▸ | MMP3 | P08254 | 1/20 | 0.39 |
| ▸ | EGLN2 | Q96KS0 | 2/20 | 0.39 |
| ▸ | SLC22A12 | Q96S37 | 1/20 | 0.39 |
| ▸ | AR | P10275 | 1/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21389009 | 0.98 | CYP1A2 (0.46) | CYP1A2CYP11B2ALDH1A1CYP2A6TSHR | |
| SCHEMBL18322222 | 0.88 | TSHR (0.52) | CYP11B2ALDH1A1CYP2A6TSHRATM | |
| SCHEMBL30451858 | 0.88 | TSHR (0.52) | CYP11B2ALDH1A1CYP2A6TSHRATM | |
| SCHEMBL22049794 | 0.87 | ALDH1A1 (0.61) | CYP11B2ALDH1A1CYP2A6TSHRATM | |
| SCHEMBL23625541 | 0.84 | CYP11B1 (0.56) | CYP1A2CYP11B2SLC22A12AR | |
| SCHEMBL23625538 | 0.81 | ADRA2C (0.48) | CYP1A2ALDH1A1TSHRMEN1KMT2A | |
| SCHEMBL23624495 | 0.79 | MAOA (0.50) | CYP1A2TSHRTNKSMMP3 | |
| SCHEMBL23624435 | 0.79 | MAOB (0.50) | CYP11B2ALDH1A1TSHRATMMEN1 | |
| SCHEMBL23625617 | 0.79 | COMT (0.51) | CYP11B2MEN1KMT2AEGLN2 | |
| SCHEMBL24617129 | 0.79 | KIF11 (0.70) | CYP11B2ALDH1A1CYP2A6TSHRKIF11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230337532-A1 | TRIAZINE COMPOUND, MATERIAL FOR ORGANIC LIGHT EMITTING DIODE, ELECTRON TRANSPORT MATERIAL FOR ORGANIC LIGHT EMITTING DIODE, AND ORGANIC LIGHT EMITTING DIODE | TOSOH CORPORATION (JP) | 2023-10-19 | — | — | US | disclosed |
| US-20230337532-A1 | TRIAZINE COMPOUND, MATERIAL FOR ORGANIC LIGHT EMITTING DIODE, ELECTRON TRANSPORT MATERIAL FOR ORGANIC LIGHT EMITTING DIODE, AND ORGANIC LIGHT EMITTING DIODE | TOSOH CORPORATION (JP) | 2023-10-19 | — | — | US | disclosed |
| WO-2022075219-A1 | TRIAZINE COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ELECTRON TRANSPORT MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, AND ORGANIC ELECTROLUMINESCENT ELEMENT | 東ソー株式会社 | 2022-04-14 | — | — | WO | disclosed |
| WO-2021135516-A1 | ORGANIC COMPOUND, ELECTRONIC COMPONENT AND ELECTRONIC APPARATUS | 陕西莱特光电材料股份有限公司 | 2021-07-08 | — | — | WO | disclosed |
| WO-2021135725-A1 | ORGANIC COMPOUND, ELECTRONIC DEVICE AND ELECTRONIC APPARATUS USING SAME | 陕西莱特光电材料股份有限公司 | 2021-07-08 | — | — | WO | disclosed |
| WO-2019031605-A1 | FUSED RING COMPOUND | 東ソー株式会社 | 2019-02-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230337532-A1 | TRIAZINE COMPOUND, MATERIAL FOR ORGANIC LIGHT EMITTING DIODE, ELECTRON TRANSPORT MATERIAL FOR ORGANIC LIGHT EMITTING DIODE, AND ORGANIC LIGHT EMITTING DIODE | ARNT, TPH1, AHR | CYP1A2 15/4885CYP11B2 277/4885ALDH1A1 61/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.